SHC
Overvalued by 148.6% based on the discounted cash flow analysis.
Market cap | $3.51 Billion |
---|---|
Enterprise Value | $3.21 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.16 |
Beta | 1.89 |
Outstanding Shares | 283,558,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 141.52 |
---|---|
PEG | -63.06 |
Price to Sales | 4.41 |
Price to Book Ratio | 13.23 |
Enterprise Value to Revenue | 2.86 |
Enterprise Value to EBIT | 10.46 |
Enterprise Value to Net Income | 45 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses - Sterigen...